Testing Clonal Relatedness of Tumors Using Array Comparative Genomic Hybridization: A Statistical Challenge
暂无分享,去创建一个
[1] N. Girard,et al. Genomic and Mutational Profiling to Assess Clonal Relationships Between Multiple Non–Small Cell Lung Cancers , 2009, Clinical Cancer Research.
[2] C. Begg,et al. Evaluation of the clonal origin of multiple primary melanomas using molecular profiling. , 2009, The Journal of investigative dermatology.
[3] Jun Luo,et al. Copy Number Analysis Indicates Monoclonal Origin of Lethal Metastatic Prostate Cancer , 2009, Nature Medicine.
[4] V. Seshan,et al. Comparison of Properties of Tests for Assessing Tumor Clonality , 2008, Biometrics.
[5] M. Relling,et al. Genome-wide copy number profiling reveals molecular evolution from diagnosis to relapse in childhood acute lymphoblastic leukemia. , 2008, Blood.
[6] M. Ringnér,et al. Tiling array-CGH for the assessment of genomic similarities among synchronous unilateral and bilateral invasive breast cancer tumor pairs , 2008, BMC clinical pathology.
[7] Emmanuel Barillot,et al. High-resolution mapping of DNA breakpoints to define true recurrences among ipsilateral breast cancers. , 2008, Journal of the National Cancer Institute.
[8] C. Schulz,et al. Glioblastoma Simultaneously Present with Meningioma - Report of Three Cases , 2007, Zentralblatt fur Neurochirurgie.
[9] A. Hartmann,et al. Epithelioid gastric stromal tumours of the antrum in young females with the Carney triad: a report of three new cases with mutational analysis and comparative genomic hybridization. , 2007, Oncology reports.
[10] C. Begg,et al. Statistical Tests for Clonality , 2007, Biometrics.
[11] J. Squire,et al. Genomic alterations in sporadic synchronous primary breast cancer using array and metaphase comparative genomic hybridization. , 2007, Neoplasia.
[12] F. Haller,et al. Multicentric Sporadic Gastrointestinal Stromal Tumors (GISTs) of the Stomach With Distinct Clonal Origin: Differential Diagnosis to Familial and Syndromal GIST Variants and Peritoneal Metastasis , 2007, The American journal of surgical pathology.
[13] J. Andersen,et al. Intratumor genomic heterogeneity in breast cancer with clonal divergence between primary carcinomas and lymph node metastases , 2007, Breast Cancer Research and Treatment.
[14] G. Gong,et al. Genetic changes in bilateral breast cancer by comparative genomic hybridisation , 2007, Clinical and Experimental Medicine.
[15] G. Giaccone,et al. Genetic Heterogeneity in Patients with Multiple Neoplastic Lung Lesions: A Report of Three Cases , 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[16] L. V. van't Veer,et al. Pulmonary Squamous Cell Carcinoma following Head and Neck Squamous Cell Carcinoma: Metastasis or Second Primary? , 2005, Clinical Cancer Research.
[17] N. Wong,et al. Clonal relationship of tumor nodules in hepatocellular carcinoma: a hierarchical clustering analysis of comparative genomic hybridization data. , 2005, Human pathology.
[18] S. Dacic,et al. Patterns of Allelic Loss of Synchronous Adenocarcinomas of the Lung , 2005, The American journal of surgical pathology.
[19] F. Waldman,et al. Clinical application of array-based comparative genomic hybridization to define the relationship between multiple synchronous tumors , 2005, Modern Pathology.
[20] S. Roychoudhury,et al. Molecular study of clonality in multifocal and bilateral breast tumors. , 2004, Pathology, research and practice.
[21] M. Wigler,et al. Circular binary segmentation for the analysis of array-based DNA copy number data. , 2004, Biostatistics.
[22] R. Lothe,et al. Assessment of clonal relationships in ipsilateral and bilateral multiple breast carcinomas by comparative genomic hybridisation and hierarchical clustering analysis , 2004, British Journal of Cancer.
[23] P. S. Larson,et al. Quantitative DNA fingerprinting may distinguish new primary breast cancer from disease recurrence. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] P. Regitnig,et al. Bilateral carcinomas of the breast with local recurrence: analysis of genetic relationship of the tumors , 2004, Modern Pathology.
[25] S. Shimizu,et al. Clonality analysis of different histological components in combined small cell and non-small cell carcinoma of the lung. , 2003, Human pathology.
[26] B. Brandt,et al. Molecular cytogenetic investigations of synchronous bilateral breast cancer , 2003, Journal of clinical pathology.
[27] G. Tse,et al. Clonal analysis of bilateral mammary carcinomas by clinical evaluation and partial allelotyping. , 2003, American journal of clinical pathology.
[28] P. V. van Diest,et al. Comparative genomic hybridisation as a supportive tool in diagnostic pathology , 2003, Journal of clinical pathology.
[29] G. Fleuren,et al. Molecular genetic evidence for monoclonal origin of bilateral ovarian serous borderline tumors. , 2003, The American journal of pathology.
[30] Richard M. Simon,et al. Methods for assessing reproducibility of clustering patterns observed in analyses of microarray data , 2002, Bioinform..
[31] E. Imyanitov,et al. Concordance of allelic imbalance profiles in synchronous and metachronous bilateral breast carcinomas , 2002, International journal of cancer.
[32] I. Wistuba,et al. Molecular analysis of synchronous and metachronous tumors of the lung: impact on management and prognosis. , 2001, Annals of diagnostic pathology.
[33] M. Gnant,et al. Contralateral Breast Cancer: Molecular Differentiation Between Metastasis and Second Primary Cancer , 2001, Breast Cancer Research and Treatment.
[34] Marie Stenmark-Askmalm, Massimiliano Gentile, Sten,et al. Protein Accumulation and Gene Mutation of p53 in Bilateral Breast Cancer , 2001 .
[35] I. Ellis,et al. Loss of Heterozygosity in Bilateral Breast Cancer , 2000, Breast Cancer Research and Treatment.
[36] J. Gillespie,et al. Genetic Changes in Contralateral Bronchioloalveolar Carcinomas of the Lung , 2000, Oncology.
[37] Y. Yatabe,et al. High frequency of clonally related tumors in cases of multiple synchronous lung cancers as revealed by molecular diagnosis. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[38] S. Devries,et al. Chromosomal alterations in ductal carcinomas in situ and their in situ recurrences. , 2000, Journal of the National Cancer Institute.
[39] T. Fujisawa,et al. Synchronous and metachronous lung carcinomas: Molecular evidence for multicentricity , 1998, Pathology international.
[40] S. Finkelstein,et al. Bronchioloalveolar adenocarcinoma of lung: monoclonal origin for multifocal disease. , 1998, The American journal of surgical pathology.
[41] J. Jen,et al. Distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma. , 1998, Journal of the National Cancer Institute.
[42] J Isola,et al. Genetic alterations in lobular breast cancer by comparative genomic hybridization , 1997, International journal of cancer.
[43] J. Benfield,et al. Clonal Origin of Multiple Lung Cancers: K‐ras and p53 Mutations Determined by Nonradioisotopic Single‐strand Conformation Polymorphism Analysis , 1997, Diagnostic molecular pathology : the American journal of surgical pathology, part B.
[44] C B Begg,et al. Biases in the assessment of diagnostic tests. , 1987, Statistics in medicine.
[45] J. H. Ward. Hierarchical Grouping to Optimize an Objective Function , 1963 .
[46] I. Petersen,et al. Chromosomal Alterations in Lung Metastases of Colorectal Carcinomas: Associations with Tissue Specific Tumor Dissemination , 2005, Clinical & Experimental Metastasis.
[47] J. Lammers,et al. p53 mutation analysis for definite diagnosis of multiple primary lung carcinoma , 2002, Cancer.
[48] M. Stenmark-Askmalm,et al. Protein accumulation and gene mutation of p53 in bilateral breast cancer. South-East Sweden Breast Cancer Group. , 2001, Acta oncologica.
[49] P. Radice,et al. Genetic evidence for an independent origin of multiple preneoplastic and neoplastic lung lesions. , 1995, Cancer research.
[50] M Staquet,et al. Methodology for the assessment of new dichotomous diagnostic tests. , 1981, Journal of chronic diseases.